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Here we describe the interaction of phosphorylated 40 kDa protein with phosphorylated Akt
which is a serine/threonine kinase resulting from increased blood glucose in rat cardiac muscle.
Mass spectrometry analysis revealed that this protein was glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH). Furthermore, increase in Akt and GAPDH phosporylation and induction of their asso-
ciation were both observed after insulin stimulation in the H9c2 cell line derived from embryonic
rat ventricle. Moreover, the activation of GAPDH was upregulated when the GAPDH phosphorylation
was increased. Our data suggest that GAPDH phosphorylation and association with Akt by insulin
treatment have some bearing on the enhancement of GAPDH activity.
Structured summary:
MINT-7891324, MINT-7891304, MINT-7891314: GAPDH (uniprotkb:P04797) physically interacts
(MI:0915) with Akt (uniprotkb:P47196) by anti bait coimmunoprecipitation (MI:0006)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Akt, which is a serine/threonine kinase, has a central role in the
regulation of several signaling pathways controlling cell survival
and proliferation [1]. This kinase has two distinct functional do-
mains: an N-terminal PH domain mediating protein-protein and
protein-lipid interactions and a C-terminal catalytic domain. The
interaction of PIP3 with the PH domain of Akt promotes the trans-
location of Akt to the plasma membrane, where it undergoes phos-
phorylation at two sites; one in the activation loop (Thr308) (by
phosphoinositide-dependent protein kinase 1 (PDK1)) and the
other in the carboxy-terminal (C-terminal) tail (Ser473) (by
PDK2) [1–3].
Insulin resistance and altered glucose and lipid metabolism in
multiple organs are deﬁned as subnormal biologic responses to achemical Societies. Published by E
, immunoprecipitate; MALDI-
e-of-ﬂight; PVDF, polyvinyli-
dehydrogenase; PDK, phos-
aba).given concentration of insulin and are characteristic of many dis-
ease states, including type 2 diabetes, obesity and normal aging
process, which collectively constitute risk factors for the develop-
ment of atherosclerotic cardiovascular disease [4–6]. The mecha-
nism underlying insulin resistance involves deleterious effects on
insulin signaling and glucose transport activity [7–9]. Insulin-in-
duced Akt phosphorylation was decreased in muscle and liver of
the animal model of insulin resistance, streptozotocin (STZ)-trea-
ted rats, compared to normal rats [10].
To date, detailed studies on insulin signaling have accumulated
signiﬁcant information. However, the full identiﬁcation of the
molecular signaling events involved in insulin actions is still in
progress.
To investigate the downstream cascade of Akt in cardiac muscle,
we used rat cardiac muscle after glucose intraperitoneal injection.
The phosphorylation of Akt was enhanced and phosphorylated
40 kDa protein (p40) interacted with Akt after glucose injection
in cardiac muscle. Peptide mass mapping of this protein revealed
that the protein is glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). GAPDH interacted with Akt after insulin stimulation
was also phosphorylated and its activity was upregulated. These re-
sults provide direct evidence for the ﬁrst time linking Akt to GAPDH.lsevier B.V. All rights reserved.
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2.1. Materials
Antibodies used for western blotting were: protein G sepharose
(GE healthcare); anti-GAPDH (Santa Cruz Biotechnology); anti-
phospho Ser/Thr/Tyr (Abcom); anti-phospho Akt (ser473); anti-
Akt (Cell Signaling Technology); anti-mouse IgG alkaline phospha-
tase conjugate (Sigma); anti-rabbit IgG alkaline phosphatase con-
jugate (Promega).
2.2. Animals
Animal experiments were performed in accordance with Junt-
endo University guidelines. Wistar rats weighing 480–510 g were
obtained from Japan SLC, Inc. (Shizuoka, Japan). They were housed
on a 12 h light–12 h dark photoperiod (lights off 09:00–21:00) in
an environmentally controlled room (23 ± 1 C, 55 ± 5% relative
humidity), and received standard rat chow and water ad libitum.
2.3. Muscle removal
Rats were fasted overnight (15–18 h) before muscle isolation.
Rats were then anesthetized with 50 mg/kg sodium pentobarbital
administered intraperitoneally. After a surgical plane of anesthesia
was reached, glucose (1 g/kg body weight) was administered by
intraperitoneal injection to the animals. Blood samples were taken
and several muscles (cardiac muscle, soleus, and extensor digito-
rum longus (EDL)) were removed quickly at 30, 60, and 120 min
after glucose injection or no glucose injection. Glucose concentra-
tions were measured with a commercial test kit (Glutest Ace R,
Sanwa Kagaku, Japan) at every time point.
2.4. Cell line, cell culture, cell stimulation
H9c2 cell line derived from embryonic rat ventricle was pro-
vided by T. Okada (Juntendo University, Tokyo, Japan). This cell line
was cultured in DMEM (Invitrogen) with 10% FBS (Biowest), and
penicillin/streptomycin at 37 C in a humidiﬁed atmosphere. Cells
(1  107) were suspended in PBS and treated with insulin (Sigma)
at 37 C.
2.5. Sample preparations
Muscles and cells were homogenized in ice-cold buffer contain-
ing 10 mM Tris-HCl (pH 7.7), 150 mM NaCl, 1% Nonidet P-40, with
PhosSTOP (Roche) and Complete (Roche). Lysates were centrifuged
for 20 min at 4 C to remove insoluble materials.
2.6. Immunoprecipitation and immunoblot analysis
Immunoprecipitation and immunoblot experiments were con-
ducted as previously described [11]. Brieﬂy, lysates were immuno-
precipitated with the appropriate Abs. Proteins were separated by
10% SDS–PAGE and transferred to polyvinylidene diﬂuoride (PVDF)
membrane. The membranes were incubated with the appropriate
Abs. The blots were visualized by incubation with alkaline phos-
phatase-labeled secondary antibody and then developed by Im-
mun-Star™AP substrate (Bio-Rad Laboratories).
2.7. Identiﬁcation of proteins by peptide mass mapping
Cardiac muscle lysates were immunoprecipitated with anti-Akt
antibody and protein G-Sepharose. The sample was separated by
10% SDS–PAGE and transferred to PVDF membrane. Then thismembrane was stained with Coomassie brilliant blue. The PVDF-
immobilized proteins were digested in situ with trypsin. Molecular
mass analyses of trypsin fragments were performed by matrix-as-
sisted laser desorption/ionization time-of-ﬂight (MALDI-TOF) mass
spectrometry using an ABI Per-Septive Biosystem Voyager DE/RP
(Applied Biosystems). Identiﬁcation of proteins was conducted by
comparison between the molecular mass determined by MALDI-
TOF/MS and theoretical peptide masses from the proteins regis-
tered in ExPASy.
2.8. Assay for GAPDH activity
The activity of GAPDH was measured spectrophotometrically
according to the methods of Stech and Kant [12] with some mod-
iﬁcation. Cell lysates were incubated in 100 mM TAPS (pH 8.5),
1 mM EDTA (pH 8.0), 1 mM NAD+, 15 mM Na3AsO4 (pH 8.0) and
10 mM dithiothreitol at 37 C for 5 min to establish a baseline.
The reaction was initiated by addition of 1 mM gryceraldehyde-
3-phosphate, and absorbance at 340 nm was measured for 5 min
at 37 C. Activity is expressed as the concentration (lM) of NADH
generated during the assay.3. Results
3.1. Phosphorylated p40 interacted with phosphorylated AKT resulting
from the increased blood glucose in rat cardiac muscle
Insulin induced by increase blood glucose level has been shown
to be involved in the activation of several cytoplasmic protein ki-
nases such as Akt, starting the metabolic signaling pathways in
muscles. To test this, we prepared the lysates from several muscles
(cardiac muscle, soleus, and EDL) of wistar rats at 30 min after glu-
cose intraperitoneal injection (GT1 and GT2) or no glucose injec-
tion (C1 and C2). The glucose levels of these rats are described in
Fig. 1D. The lysates were analyzed by anti-phospho Akt antibody
immunoblotting. Akt in soleus and EDL were phosphorylated in
each case. In contrast, the phosphorylation level of Akt in cardiac
muscle was upregulated at high blood glucose level, whereas the
expression levels of Akt in cardiac muscles were similar (Fig. 1A).
The bands just below the phospho-Akt bands did not cross-react
with anti-Akt antibody. Therefore, these are non-speciﬁc bands
which cross-react with phospho-Akt antibody. These results indi-
cated that blood glucose level determined a good part of the phos-
phorylation level of Akt in cardiac muscle. It is highly likely that
the downstream cascade of Akt in cardiac muscle was different
from that in others, so we investigated what interacts with phos-
phorylated Akt in cardiac muscle. The lysates from cardiac muscles
of C1, C2, GT1, GT2 were immunoprecipitated with anti-Akt anti-
body, and the precipitates were analyzed by anti-phospho Ser/
Thr/Tyr antibody immunoblotting. In particular, the degree of
phosphorylation of 40 kDa protein (p40) interacted with Akt
was markedly increased in GT1 cardiac muscle (Fig. 1B, upper pa-
nel, arrow). In contrast, the amounts of the band in C1, C2 and GT2
cardiac muscles were marginal. Despite the fact that it was a glu-
cose-injected rat, GT2 cardiac muscle did not show a reaction sim-
ilar to GT1. This is because this reaction may correlate with the
blood glucose levels. Reprobing of the blot for Akt revealed that
the amounts of Akt in each sample were very similar. Thus, we
speculate that this protein is a novel target of Akt.
3.2. Identiﬁcation of p40
p40 was partially puriﬁed and molecular mass analyses were
performed as described in Section 2. According to this data, p40
represented GAPDH (Table 1). Therefore, we conducted experi-
Fig. 1. Phosphorylated p40 interacts with Akt after glucose injection in cardiac
muscle. Cardiac muscle, soleus, and EDL were removed from the rats at 30 min after
glucose injection (GT1 and GT2) or no injection (C1 and C2). Representative results
of separate experiments are shown in (A–D). (A) Lysates from muscles were
prepared and analyzed by anti-phospho Akt and then anti-Akt blot. (B) Lysates from
muscles were prepared and immunoprecipitated with anti-Akt antibody. Immu-
noprecipitates (IPs) were analyzed by anti-phospho-Ser/Thr/Tyr and then anti-Akt
blot. (C) Lysates from cardiac muscle were prepared and immunoprecipitated with
anti-Akt antibody. IPs were analyzed by anti-GAPDH and then anti-Akt blot. (D)
Blood glucose concentrations were measured by blood glucose monitor.
Table 1
Molecular mass analysis of trypsin peptides.
Observed
mass
(Da)
Theoretical
mass (Da)
D
mass
(Da)
Sequences Positions
2244.12 2244.09 0.03 R VIISAPSADAPMFVMGVNHEK Y 117–137
738.35 738.35 0.00 K YDNSLK I 138–143
2610.42 2610.35 0.07 K
VIHDNFGIVEGLMTTVHAITATQK
T
161–184
1368.76 1368.74 0.02 K LTGMAFR V 199–213
810.40 810.41 0.00 K LTGMAFR V 226–232
1569.85 1569.82 0.03 R VPTPNVSVVDLTCR L 233–246
812.43 812.44 0.01 K QAAEGPLK G 262–269
1778.82 1778.79 0.03 K LISWYDNEYGYSNR V 308–321
1258.61 1258.59 0.02 R VVDLMAYMASK E 322–332
Match to: GAPDH.
Sequence coverage: 36%.
Fig. 2. Relationship between phosphorylation level of GAPDH and blood glucose
level. Representative results of separate experiments are shown in (A) and (B). (A)
Cardiac muscle was removed from each rat at 30 min (GT330min), 60 min (GT460min),
120 min (GT5120min) after glucose injection and from control rats (no glucose
injection) (C3). Lysates were prepared and immunoprecipitated with anti-GAPDH
antibody. IPs were analyzed by anti-phospho-Ser/Thr/Tyr and then anti-GAPDH
blot. (B) Blood glucose concentrations were measured by blood glucose monitor at
every time point.
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muscles of C1, C2, GT1, GT2 were immunoprecipitated with anti-
Akt antibody, and the precipitates were investigated by anti-GAP-
DH antibody blot experiments. The result shown in Fig. 1C indi-
cates that Akt interacts with GAPDH upon blood glucose level
increase in cardiac muscle. This result suggests that Akt and GAP-DH are linked not by glucose injection time but by blood glucose
level.
3.3. The relationship between phosphorylation level of GAPDH and
blood glucose level
To investigate the relationship between phosphorylation level
of GAPDH and blood glucose level, the lysates from cardiac muscles
of wistar rats at 30, 60, 120 min after glucose intraperitoneal injec-
tion (GT330min, GT460min, and GT5120min) or no glucose injection
(C3) were immunoprecipitated with anti-GAPDH antibody, and
the precipitates were examined by anti-phospho Ser/Thr/Tyr anti-
body. The glucose levels of these rats are described in Fig. 2B. The
result demonstrated that GAPDH phosphorylation was upregu-
lated at high blood glucose level after glucose injection, then GAP-
DH phosphorylation returned to the original level followed by the
decrease of blood glucose level within 120 min in cardiac muscle
(Fig. 2A). The phosphorylation of GAPDHwas marginal on the mus-
cles (soleus and EDL) other than cardiac muscle regardless of the
change of the blood glucose level (data not shown).
3.4. GAPDH interacts with AKT after insulin stimulation in H9c2 cell
line
In order to investigate whether Akt interacts with GAPDH after
insulin stimulation, we used a H9c2 cell line derived from embry-
onic rat heart that can serve as a surrogate for cardiac muscle
in vitro. H9c2 cells resuspended in PBS were treated with, or with-
out, insulin (ﬁnal concentration: 100 nM). The lysates were ana-
lyzed by anti-phospho Akt antibody immunoblotting.
Phosphorylation of Akt was induced by 15 min insulin treatment
(Fig. 3A). The phosphorylation level was sustained for 30 min (data
not shown). On the other hand, phosphorylation of Akt diminished
Fig. 3. GAPDH Interacts with AKT after insulin stimulation in H9c2 cell line. H9c2
cells were treated with or without insulin and then had insulin ﬂushed out with PBS
after 15 min insulin treatment. Blots representative of separate experiments are
shown. Evaluation data of band densities of the immunoblots using Image J
software are expressed as means ± S.E.M. for 3 independent experiments in all
cases. (A) Lysates were prepared and analyzed by anti-phospho Akt and then anti-
Akt blot. (B) Lysates were prepared and immunoprecipitated with anti-GAPDH
antibody. IPs were analyzed by anti-AKT or anti-phospho-Ser/Thr/Tyr blot. The blot
was then reprobed with anti-GAPDH antibody. (C) Lysates were prepared and
immunoprecipitated with anti-Akt antibody. IPs were analyzed by anti-GAPDH and
then anti-Akt blot.
Fig. 4. The effects of insulin on GAPDH activity. H9c2 cells resuspended in PBS were
treated with or without insulin and then had insulin ﬂushed out with PBS after
15 min insulin treatment. Blots representative separate experiments are shown. (A)
Lysates were prepared and immunoprecipitated with anti-GAPDH antibody. IPs
were analyzed by anti-phospho-Ser/Thr/Tyr and then anti-GAPDH blot. (B) The
reactions were conducted as already described in Section 2. The measurements
were repeated 3 times for each of the 3 experiments. Results are shown as
means ± S.E.M.
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insulin treatment (Fig. 3A). These results indicate that insulin
determines the phosphorylation status of Akt. Furthermore, phos-
phorylation level of GAPDH was upregulated with increase of Akt
phosphorylation after 15 min insulin treatment, and then, phos-
phorylated GAPDH was reduced concomitantly with the decrease
of phosphorylated Akt after washing away insulin (Fig. 3B). More-
over, more GAPDH molecules were interacted with Akt when both
of them were hyper-phosphorylation status (Fig. 3B and C). The re-
sults suggest that phosphorylation status of GAPDH and interac-tion between Akt and GAPDH correlate closely with
phosphorylation status of Akt after insulin stimulation in H9c2 cell
line.
3.5. The relationship between phosphorylation status of GAPDH and
activity of GAPDH
To investigate the relationship between phosphorylation status
of GAPDH and activity of GAPDH, GAPDH activity was determined
in whole lysates taken from H9c2 cell lines treated with, or with-
out, insulin. GAPDH exhibited greater activity with the increased
phosphorylation level of GAPDH after insulin stimulation, and
then, GAPDH activity was reduced concomitantly with the de-
crease of phosphorylated GAPDH after washing away insulin in
the cell line (Fig. 4A and B). Therefore, the results suggest that
the phosphorylation of GAPDH has some kind of connection with
GAPDH activity.
4. Discussion
Insulin participates in the regulation of glucose uptake, protein
synthesis, and vascular tonicity. Among the signal transduction
mechanisms involved in these insulin effects, Akt pathway is
thought to play a crucial role. However, the full identiﬁcation of
2800 T. Baba et al. / FEBS Letters 584 (2010) 2796–2800insulin-induced activation has not yet been actually demonstrated
in cardiac tissue.
To investigate the downstream cascade of Akt in cardiac muscle,
we used several rat muscles after glucose intraperitoneal injection.
In cardiac muscle, phosphorylation of Akt had a direct correlation
with blood glucose level compared with soleus and EDL after glu-
cose injection. We speculate that Akt in soleus and EDL were phos-
phorylated regardless of glucose injection because Akt is situated
at a critical juncture where it responds to inhibition of apoptosis
and protein degradation in skeletal muscle. Phosphorylation of
p40 was interacted with Akt in cardiac muscle after glucose injec-
tion. This protein turned out to be GAPDH. Furthermore, the inter-
action between GAPDH and Akt was induced by insulin stimulation
in H9c2 cell line derived from embryonic rat heart. These results
suggest that there is a novel Akt/GAPDH signal cascade not in skel-
etal muscle but in cardiac muscle. GAPDH is one of the abundant
proteins in the cell. Therefore, we ruled out the possibility of
non-speciﬁc detection of the Akt/GAPDH complex (Fig. 3). Akt
phosphorylates a wide array of downstream effector proteins.
Therefore, our data suggest that Akt activated by insulin may phos-
phorylate GAPDH as new substrate.
GAPDH is commonly known as an enzyme that catalyzes the
sixth step of glycolysis (GAPDH catalyzes the NAD-mediated oxida-
tive phosphorylation of glyceraldehyde 3-phosphate to 1,3-diphos-
phoglycerate) and thus serves to break down glucose for energy
and carbon molecules. Recent reports demonstrate that GAPDH
has been implicated in several non-metabolic processes. Hara,
et al. demonstrated that GAPDH is S-nitrosylated by NO in re-
sponse to cell stress, which causes it to bind to a ubiquitin ligase,
Siah1, and initiates apoptosis [13]. Therefore, the modiﬁcation sta-
tus of GAPDHmay play a pivotal role in its function. Another paper
suggests that GAPDH is phosphorylated by PKC i/k and that it plays
a role in microtubule dynamics in the early sectetory pathway in
kidney cells [14]. However, the relationship between phosphoryla-
tion status of GAPDH and activity of GAPDH has remained un-
known. Therefore, to investigate this relationship, activity of
phosphorylated GAPDH induced by insulin was determined by
analysis for the presence of NADH from NAD+. We demonstrated
that GAPDH has greater activity in response to the increase of
phosphorylation level of GAPDH in the H9c2 cell line after insulin
stimulation.
In conclusion, we suggest that insulin treatment triggers GAP-
DH phosphorylation and association with Akt, and that GAPDH
phosphorylation in response to insulin stimulation may correlatewith the enhancement of GAPDH enzymatic activity. These results
demonstrate for the ﬁrst time the interaction of Akt with GAPDH in
cardiac muscle.
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